You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Sandu Pharmaceuticals Ltd"

Sandu Pharmaceuticals Ltd Closure of Trading Window

  • 27/06/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Related Party Transaction Disclosure Under Regulation 23(9) For Half Year Ended 31.03.2022

  • 04/06/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Newspaper Publication In Respect Of The Audited Financial Results For The Q And Year Ended 31.03.202

  • 01/06/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Statement Of Deviation And Variation Of Funds For Q Ended 31St March 2022

  • 30/05/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Audited Financial Results For The Year Ended 31ST March 2022

  • 30/05/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th May 2022

  • 30/05/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance

  • 26/05/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 25/05/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended 31St M

  • 15/05/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations An

  • 23/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Certificate Under Regulation 40(9) Of SEBI (LODR) Regulation 2015 For The Year Ended 31St March 2022

  • 20/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Trading Of 889667 Equity Shares Of Rs. 10/- Each Issued At A Premium Of Rs. 10.69/- BearingDistincti

  • 18/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022

  • 18/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Compliance Certificate For Q Ended 31St March 2022

  • 08/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 08/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 06/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 05/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Disclosure Under Reg 30 -Intimation To Physical Shareholders To Furnish Their PANKYC And Nomination

  • 04/04/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Intimation About Listing Approval For 02Nd Tranche Of Equity Warrants Conversion Into Equity Shares

  • 29/03/2022
  • |
  • bse

Sandu Pharmaceuticals Ltd Closure of Trading Window

  • 21/03/2022
  • |
  • bse
.